How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MD

XETRA:Medigene
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MD

Medigene AGXETRA Medigene Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XETR - Xetra

FAIR VALUE

Is MDG1 undervalued compared to its fair value?

The fair value of MDG1 stock is hidden EUR. Relative to the market price of 1.165 EUR Medigene AG is hidden.

MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company is headquartered in Planegg, Bayern and curren...[More about valuation]

Medigene AG Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.037 $B

Price:

1.165 EUR

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

FINANCIALS

Medigene AG financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Balance Sheet

Financial Position Analysis

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Medigene AG fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Medigene Rating

Is MDG1 attractive for investment based on fundamental analysis?

MDG1 stock rating is hidden. Medigene AG is a hidden by Eyestock methodology.

Get MDG1 Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

MDG1.DE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for MDG1.DE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Medigene AG dividends

MDG1.DE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About MDG1.DE stock

About the company Medigene AG

Market cap $B

0.037

Dividend yield

Shares outstanding

24.5627 B

MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company is headquartered in Planegg, Bayern and currently employs 64 full-time employees. The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.

MDG1.DE profile

  • Ticker

    MDG1.DE

  • Country

    Germany

  • Exchange

    XETR - Xetra

  • Report currency

    EUR - Euro

  • IPO date

    30 June 2000

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    64

  • City

    Planegg

  • Address

    Lochhamer Strasse 11

  • Cusip

    D5326M178

Frequently Asked Questions

What sector does Medigene operate in?

Medigene operates in Healthсare sector

What is market cap of Medigene?

Market cap of Medigene is 0.037 USD as of 24 Jul 2024

What is market price of one MDG1 stock?

Market price of one MDG1 stock is 1.165 EUR as of 24 Jul 2024

What is Medigene revenue?

According to the recent report Medigene revenue is —

What is Medigene net income?

According to the recent report Medigene net icnome is —

What is Medigene net income growh rate?

Net income growth rate of Medigene is —